Archives of Digestive Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Original Article - Archives of Digestive Disorders (2017) Volume 0, Issue 0

Prevalence and risk factors of new onset diabetes after liver transplantation (NODAT): A single Egyptian center experience

Aim: To estimate the prevalence of New Onset Diabetes after Liver Transplantation (NODAT) and to investigate the possible risk factors. Methods: This retrospective study comprises 213 patients subjected to living donor liver transplantation (LDLT). Patients’ data were collected from medical registry files for a period of two years after transplant. Results: Of the total 213 recipients, complete data for the whole study period were available for 164 recipients who were enrolled in this study. Fifty one 51 (31.1%) patients were already diabetic prior to transplantation. The prevalence of NODAT was 27.43% (31/113). Eight of NODAT cases (25.8%) were transient with recovery within 6-months period in 5/8 cases while the other 3 cases recovered in more than 6 months to a year. The only drug that showed statistically significant difference was tacrolimus (p=0.02). Interestingly, three pre-transplant diabetics (3/51, 5.9%) recovered after liver transplant with elimination of their anti-diabetic therapy. Conclusion: NODAT is a common medical complication that occurs in 27.4% of liver transplant recipients. The study suggests using one year cutoff rather than 6 months for defining transient NODAT. Post-transplant tacrolimus-based immunosuppression is a significant independent predictor of NODAT development

Author(s): Reham Adly Zayed, Monir Hussein Bahgat, Mohammed Abdel Wahab, Shahira El-Etreby, Rokiah Anwar Saad, Fayez Moustafa Elmorsy

Abstract Full Text PDF